Merganser Biotech Inc. Appoints Remy Sukhija As Chief Operating Officer

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Merganser Biotech Inc. ("Merganser"), a preclinical stage biotech company focused on the development of hepcidin mimetic peptides for the treatment of rare hematology and iron overload diseases, announced today that Remy Sukhija has been appointed to the role of Chief Operating Officer, effective immediately.